Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Evidence-Based Medicine. Found 10 abstracts

Weinberg DS, Smalley W, Heidelbaugh JJ, Sultan S. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology. 2014 Nov;147(5):1146-8.
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10;27(23):3868-74.
O'Sullivan MJ, Morrow M. Ductal carcinoma in situ--current management. Surgical Clinics of North America. 2007 Apr;87(2):333-51.
Pagoto SL, Spring B, Coups EJ, Mulvaney S, Coutu MF, Ozakinci G. Barriers and facilitators of evidence-based practice perceived by behavioral science health professionals. J Clin Psychol. 2007 Jul;63(7):695-705.
Rubins J, Unger M, Colice GL. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007 Sep;132(3 Suppl):355S-367S.
Andrykowski MA, Manne SL. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. Ann Behav Med. 2006 Oct;32(2):93-7.
Daly MB. Genetic screening and counseling for high-risk populations. Chang AE, Ganz P, Hayes D, Kinsella H, Pass H, Schiller J, Stone R, Strecher V, editors. New York, NY: Springer; 2006.
Barsevick AM, Sweeney C, Haney E, Chung E. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum. 2002 Jan;29(1):73-84; quiz 85-7.
Langer CJ. Elderly patients with lung cancer: biases and evidence. Current treatment options in oncology. 2002 Feb;3(1):85-102.
Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002 Aug;20(15):3317-27.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Evidence-Based Medicine

Evidence-Based Medicine therapy diagnosis Neoplasms etiology Treatment Outcome therapeutic use Female Human methods United States Attitude to Health Non-US Gov't Support economics Medical Oncology Antineoplastic Agents complications Randomized Controlled Trials Breast Neoplasms Tamoxifen Hormonal Antineoplastic Agents Drug Costs drug therapy Lung Neoplasms psychology standards Adjuvant Chemotherapy prevention & control Counseling Biomedical Technology Sentinel Lymph Node Biopsy Withholding Treatment Patient Education as Topic Insurance Coverage Irritable Bowel Syndrome Social Support Physician-Patient Relations Attitude of Health Personnel Behavioral Medicine Radiotherapy Male Constipation Review Literature as Topic adverse effects Practice Guidelines Combination Drug Therapy Nursing Assessment Evidence-based medicine Diffusion of Innovation Patient Education Triazoles Cost-Benefit Analysis Behavior Therapy Health Insurance Expert Testimony Ductal Carcinoma-Breast Segmental Mastectomy Mastectomy 10540-29-1 (Tamoxifen) Research Design Cancer enzymology Major Depressive Disorder Oncology Smoking Cessation Nitriles Oncologic Nursing Age Factors Risk Factors Survival Analysis su [Surgery] Hormonal) 0 (Antineoplastic Agents Drug Industry Communication Prejudice Disease-Free Survival Cognitive Therapy Gastrointestinal Agents Postmenopause Gastroenterology Aged Depressive Disorder trends Local Neoplasm Recurrence Carcinoma in Situ Second Primary Neoplasms pathology Neoplasm Staging Survival Rate antagonists & inhibitors Aromatase Non-Small-Cell Lung Carcinoma tu [Therapeutic Use] Adjuvant Radiotherapy Data Collection Medical Societies Medical Education-Continuing Health Care Costs Enzyme Inhibitors
Last updated on Wednesday, March 04, 2020